Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company operates as a life sciences company. Its activities include researching, developing, and marketing plasma proteins, biosimilars, and proteins.
Reliance Life Sciences Private Limited, is an unlisted private company incorporated on 30 January, 2001. It is classified as a private limited company and is located in Navi Mumbai, Maharashtra. It's authorized share capital is INR 126.01 cr and the total paid-up capital is INR 96.01 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 987.1 | 1,332.3 | 1,969.5 | 2,478.5 | 2,206.3 |
Operating profit | 207.6 | 344.4 | 802.8 | 1,032.8 | 800.2 |
Net profit | 58.5 | 119.4 | 468.5 | 592.7 | 413.1 |
Gross margin | 53.5 | 51.9 | 62.0 | 65.4 | 59.5 |
Operating margin | 21.0 | 25.9 | 40.8 | 41.7 | 36.3 |
Net margin | 5.8 | 8.7 | 23.2 | 23.4 | 18.2 |
Networth | 395.0 | 514.4 | 983.7 | 1,575.7 | 1,987.7 |
Borrowings | 578.9 | 635.5 | 738.7 | 957.2 | 1,121.6 |
Assets | 1,213.3 | 1,418.5 | 2,091.7 | 2,948.6 | 3,434.1 |
Debt to equity | 1.5 | 1.2 | 0.8 | 0.6 | 0.6 |
Current ratio | 2.5 | 3.2 | 3.3 | 4.0 | 2.6 |
ROE | 14.8 | 23.2 | 47.6 | 37.6 | 20.8 |
Days payable | 128.0 | 117.0 | 123.0 | 116.0 | 89.0 |
WC days | 132.0 | 163.0 | 151.0 | 178.0 | 127.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 115.8 | 115.8 | 96.0 | 96.0 | 96.0 |
Reserves | 279.3 | 398.6 | 887.7 | 1,479.7 | 1,891.7 |
Borrowings + | 578.9 | 635.5 | 738.7 | 957.2 | 1,121.6 |
Long term borrowings | 576.8 | 635.0 | 738.7 | 957.2 | 961.3 |
Short term borrowings | 2.1 | 0.5 | - | - | 160.3 |
Trade payables + | 161.5 | 205.5 | 253.3 | 272.2 | 218.3 |
Days payable | 128.0 | 117.0 | 123.0 | 116.0 | 89.0 |
Other liabilities + | 239.4 | 268.7 | 369.2 | 415.6 | 324.7 |
Other non-current liabilities | 4.7 | 5.1 | 6.8 | 6.0 | 6.6 |
Other current liabilities | 73.2 | 58.0 | 109.1 | 137.4 | 99.9 |
Total liabilities | 1,213.3 | 1,418.5 | 2,091.7 | 2,948.6 | 3,434.1 |
Fixed Assets + | 599.7 | 524.6 | 719.9 | 730.5 | 764.0 |
Tangible assets | 293.1 | 281.3 | 447.6 | 496.9 | 666.7 |
CWIP | 4.8 | 15.0 | 112.2 | 139.5 | 68.7 |
Intangible assets | 301.8 | 228.4 | 160.2 | 94.1 | 28.6 |
LT loans and advances | 19.0 | 25.6 | 0.4 | 0.2 | 0.1 |
Other non-current assets | 1.6 | 10.4 | 191.4 | 600.8 | 1,424.3 |
Current assets + | 593.1 | 857.9 | 1,179.8 | 1,617.1 | 1,245.7 |
Inventories | 236.6 | 320.6 | 317.5 | 347.8 | 419.1 |
Trade receivables | 135.0 | 108.1 | 128.2 | 127.7 | 291.9 |
Cash and cash equivalents | 4.9 | 16.1 | 3.0 | 6.8 | 11.1 |
ST loans and advances | 60.4 | 77.9 | 0.8 | 1.1 | 0.4 |
Other current assets | 156.2 | 335.2 | 730.3 | 1,133.7 | 523.2 |
Total assets | 1,213.3 | 1,418.5 | 2,091.7 | 2,948.6 | 3,434.1 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 987.1 | 1,332.3 | 1,969.5 | 2,478.5 | 2,206.3 |
Sales growth % | 20.76 | 34.98 | 47.82 | 25.85 | -10.98 |
Expenses + | 929.8 | 1,182.8 | 1,373.2 | 1,718.1 | 1,687.2 |
Cost of goods | 459.1 | 641.6 | 749.4 | 857.3 | 893.4 |
Employee cost | 115.2 | 127.3 | 158.2 | 190.6 | 214.5 |
Other costs | 205.1 | 219.0 | 259.1 | 397.8 | 298.2 |
Operating profit + | 207.6 | 344.4 | 802.8 | 1,032.8 | 800.2 |
Operating margin % | 21.0 | 25.9 | 40.8 | 41.7 | 36.3 |
Other income | 15.7 | 35.6 | 53.0 | 55.6 | 57.9 |
Interest | 54.9 | 59.9 | 70.0 | 86.4 | 95.1 |
Depreciation | 95.5 | 135.0 | 136.6 | 186.1 | 186.1 |
Exceptional items | 14.0 | - | - | - | - |
Profit before tax | 85.4 | 183.8 | 649.2 | 816.0 | 576.9 |
Tax | 26.9 | 64.4 | 180.7 | 223.3 | 163.8 |
Profit - disc. ops | - | - | - | - | - |
Net profit | 58.5 | 119.4 | 468.5 | 592.7 | 413.1 |
Net margin % | 5.8 | 8.7 | 23.2 | 23.4 | 18.2 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 1.5 | 1.2 | 0.8 | 0.6 | 0.6 |
Net Debt/Equity | 1.4 | 1.2 | 0.8 | 0.6 | 0.6 |
Total Debt/Assets | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 |
Total Assets/Equity | 3.1 | 2.8 | 2.1 | 1.9 | 1.7 |
Liquidity + | |||||
Current Ratio | 2.5 | 3.2 | 3.3 | 4.0 | 2.6 |
Quick Ratio | 1.5 | 2.0 | 2.4 | 3.1 | 1.7 |
Interest Coverage | 3.8 | 5.8 | 11.5 | 12.0 | 8.4 |
Performance | |||||
Gross Margin | 53.5 | 51.9 | 62.0 | 65.4 | 59.5 |
Operating Margin | 21.0 | 25.9 | 40.8 | 41.7 | 36.3 |
Net Margin | 5.8 | 8.7 | 23.2 | 23.4 | 18.2 |
Return + | |||||
Return on Equity | 14.8 | 23.2 | 47.6 | 37.6 | 20.8 |
Pre-tax ROCE | 11.7 | 18.7 | 43.3 | 43.7 | 40.1 |
Return on Assets | 4.8 | 8.4 | 22.4 | 20.1 | 12.0 |
Pre-tax ROIC | 11.6 | 18.5 | 38.8 | 33.5 | 19.8 |
Efficiency + | |||||
Days Payable | 128.0 | 117.0 | 123.0 | 116.0 | 89.0 |
Days Inventory | 188.0 | 182.0 | 155.0 | 148.0 | 171.0 |
Days Receivable | 50.0 | 30.0 | 24.0 | 19.0 | 48.0 |
Fixed Asset Turnover | 1.6 | 2.5 | 2.7 | 3.4 | 2.9 |
Total Asset Turnover | 0.8 | 0.9 | 0.9 | 0.8 | 0.6 |
Working Capital | |||||
Cash Conversion Cycle | 110.0 | 95.0 | 56.0 | 51.0 | 130.0 |
Working Capital Days | 132.0 | 163.0 | 151.0 | 178.0 | 127.0 |
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 1,000.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 350.0 cr
State Bank of India
No. of Loans: 2
Total Amount : 11.0 cr
Canara Bank
No. of Loans: 1
Total Amount : 5.6 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Vinay Arvind Ranade | 00006568 | 9 years |
Director | Laxmidas Vallabhdas Merchant | 00007722 | 18 years |
Whole-time Director | Ramaprasad Jayaraman | 01555571 | 9 years |
Whole-time Director | Venkata Ramana | 02256718 | 3 years |
Whole-time Director | Shailaja Gada Saxena | 09451446 | 3 years |
CS | Hardeep Singh Sodhi | <HIDDEN> | 11 years |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
RELIANCE LIFE SCIENCES NASHIK PRIVATE LIMITED | Maharashtra | 2022 | ₹ 900.0 Cr |
The incorporation date of RELIANCE LIFE SCIENCES PRIVATE LIMITED is 30 January, 2001
The authorized share capital of RELIANCE LIFE SCIENCES PRIVATE LIMITED is INR ₹ 126.0 Cr.
The paid-up capital of RELIANCE LIFE SCIENCES PRIVATE LIMITED is INR ₹ 96.0 Cr.
The registered address of RELIANCE LIFE SCIENCES PRIVATE LIMITED is DHIRUBHAI AMBANI LIFE SCIENCES CENTRE R-282 TTC AREA OF MI DC, THANE BELAPUR RO AD, RABALE NA NAVI MUMBAI Maharashtra - 400701
The CIN number of RELIANCE LIFE SCIENCES PRIVATE LIMITED is U24239MH2001PTC130654.